|
FY2026
12 months to Jun 27, 2026
|
FY2025
12 months to Jun 28, 2025
|
FY2024
12 months to Jun 29, 2024
|
FY2023
12 months to Jul 1, 2023
|
FY2022
12 months to Jul 2, 2022
|
|
|---|---|---|---|---|---|
| OPERATING ACTIVITIES: | |||||
| Net (loss) income | |||||
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: | |||||
| Depreciation expense | |||||
| Stock-based compensation | |||||
| Gain on sale of product lines | |||||
| Amortization of acquired intangibles | |||||
| Bad debt expense | |||||
| Changes in income tax valuation allowance | |||||
| Amortization and write-off of acquired intangible assets | |||||
| Write-off of right-of-use assets | |||||
| Write-down and loss on sales and dispositions of property, plant and equipment | |||||
| Loss on debt extinguishment | |||||
| Amortization of debt issuance costs | |||||
| Amortization of inventory fair value adjustment in connection with acquisition | |||||
| Gain on repurchase of convertible notes | |||||
| Inducement expense on partial repurchase of 2026 Notes | |||||
| Gain on sale of facility | |||||
| Other non-cash income, net | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Operating lease right-of-use assets, net | |||||
| Prepayments and other current and non-currents assets | |||||
| Income taxes, net | |||||
| Accounts payable | |||||
| Accrued payroll and related expenses | |||||
| Operating lease liabilities | |||||
| Accrued expenses and other current and non-current liabilities | |||||
| Net cash provided by operating activities | |||||
| INVESTING ACTIVITIES: | |||||
| Payments for acquisition of property, plant and equipment | |||||
| Acquisition of businesses, net of cash acquired | |||||
| Payment for acquisition of intangible assets | |||||
| Purchases of short-term investments | |||||
| Proceeds from maturities and sales of short-term investments | |||||
| Term loan funding provided to NeoPhotonics | |||||
| Proceeds from sale of facility, net of cash and selling costs | |||||
| Proceeds from the sales of property and equipment | |||||
| Net cash used in investing activities | |||||
| FINANCING ACTIVITIES: | |||||
| Proceeds from the issuance of Series A Convertible Preferred Stock | |||||
| Proceeds from the issuance of 2029 Notes, net of issuance costs | |||||
| 2029 Notes | |||||
| 2028 Notes | |||||
| Total proceeds from the issuance of 2029 Notes, net of issuance costs | |||||
| Proceeds from term loans | |||||
| Proceeds from employee stock plans | |||||
| Payment for partial repurchase of 2026 Notes | |||||
| Cash paid for conversions of convertible notes | |||||
| Payment, repurchase and conversion of 2024 Notes | |||||
| Principal payments on term loans | |||||
| Repurchase of common stock | |||||
| Payment of withholding taxes related to net share settlement of restricted stock units | |||||
| Payment of acquisition related holdback | |||||
| Payment for financing costs related to revolving credit facility | |||||
| Net cash provided by (used in) financing activities | |||||
| Increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid for taxes, net | |||||
| Cash paid for interest | |||||
| Supplemental disclosure of non-cash transactions: | |||||
| Unpaid property, plant and equipment in accounts payable and accrued expenses | |||||
| Property, Plant and Equipment | |||||
| Finite-Lived Intangible Assets | |||||
| Settlement of loan to NeoPhotonics | |||||
| 2029 Notes issuance costs in current liabilities | |||||
| Right-of-use assets obtained in exchange for new operating lease liabilities | |||||
| Net transfer of assets from property, plant, and equipment to assets-held-for-sale | |||||
| Holdback receivable from sale of property, plant, and equipment | |||||
| Share-based purchase price consideration in connection with the Cloud Light acquisition | |||||
| Repurchase of common stock pending settlement | |||||
| Aggregate principal amount of the convertible notes settled through issuance of common stock (equitization) | |||||
Loading...